Supported by Mexican Federal Funds HIM,No.2018/068 SSA152.
BACKGROUND Autoimmunity has emerged as a probable disease modifier in patients with clinically diagnosed type 2 diabetes mellitus(T2DM),that is,patients who have insulin resistance,obesity,and other cardiovascular ris...
Supported by Grants from the National Institute of Diabetes and Digestive Kidney Diseases,No.R01 DK032083,K08 DK095995;Juvenile Diabetes Research Foundation;the Children’s Diabetes Foundation;the Brehm Coalition
Type 1 diabetes(T1D) is an autoimmune disease characterized by loss of insulin producing beta cells and reliance on exogenous insulin for survival.T1 D is one of the most common chronic diseases in childhood and the i...
Ever since its first appearance among the multiple forms of diabetes,latent autoimmune diabetes in adults(LADA),has been the focus of endless discussions concerning mainly its existence as a special type of diabetes.I...
We have previously reported the high levels of glutamic acid decarboxylase 65 autoantibodies(GAD65A)in patients with type 1 diabetes and autoimmune thyroid disease.Here we describe a 32-year-old Japanese female with a...
Latent autoimmune diabetes in adults(LADA) accounts for 2-12 of all cases of diabetes.Patients are typically diagnosed after 35 years of age and are often misdiagnosed as type Ⅱ Diabetes Mellitus(DM).Glycemic control...